← FDA DRUG APPROVALS

FDA ANDA · ANDA090424

ONDANSETRON HYDROCHLORIDE

Sponsor: AVET LIFESCIENCES

APPLICATION
ANDA090424
TYPE
ANDA
ORIGINAL APPROVAL
2010-04-16
LATEST ACTION
2023-04-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ONDANSETRON HYDROCHLORIDEDiscontinued
ONDANSETRON HYDROCHLORIDE EQ 2MG BASE/ML · INJECTABLE · INJECTION

Approval history

2023-04-19Labeling · Supplement 19 · standardAP
2021-08-18Labeling · Supplement 16 · standardAP
2021-08-18Labeling · Supplement 18 · standardAP
2015-01-15Labeling · Supplement 5 · standardAP
2015-01-15Labeling · Supplement 8 · standardAP
2015-01-15Labeling · Supplement 4 · standardAP
2015-01-15Labeling · Supplement 2 · standardAP
2010-04-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →